Xspray Pharma: RightSize to rule them all?
Initiating Coverage
2018-03-21
07:30
We are initiating coverage of Xspray Pharma, a Swedish biopharma with a unique business model. Three product candidates are lined up to reach the market between 2020-2023, and it is our belief that Xspray can utilize their RightSize technology platform to become a niche generic player that can out-maneuver other market players.
MS
Mathias Spinnars
Disclosures and disclaimers